Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Xiang Liang

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Epidemiology|May 21, 2010
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancerWei-De Zhong, Qing-Biao Chen, Yong-Kang Ye, et al.
Disease Markers|May 13, 2022
Tumor Suppressor Role and Clinical Significance of the <i>FEV</i> Gene in Prostate CancerYu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, et al.
Pathology Oncology Research : POR|August 24, 2011
Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcomeHui-Chan He, Jia-Hong Chen, Xi-Bin Chen, et al.
Pathology Oncology Research : POR|April 19, 2011
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerChao Cai, Fu-neng Jiang, Yu-xiang Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 1, 2012
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomasXue-Cheng Bi, Jiu-Min Liu, Hui-Chang He, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Molecular Biology Reports|January 24, 2014
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerXiao-hui Ling, Zhao-dong Han, Dan Xia, et al.
Nature Neuroscience|February 24, 2018
Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletionYubin Huang, Zhen Xu, Shanshan Xiong, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancerChao Cai, Jin-Yan Chen, Zhao-Dong Han, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Epidemiology|May 21, 2010
Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancerWei-De Zhong, Qing-Biao Chen, Yong-Kang Ye, et al.
Disease Markers|May 13, 2022
Tumor Suppressor Role and Clinical Significance of the <i>FEV</i> Gene in Prostate CancerYu-Xiang Liang, Ying-Ke Liang, Zhi-Hao Zou, et al.
Pathology Oncology Research : POR|August 24, 2011
Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcomeHui-Chan He, Jia-Hong Chen, Xi-Bin Chen, et al.
Pathology Oncology Research : POR|April 19, 2011
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerChao Cai, Fu-neng Jiang, Yu-xiang Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 1, 2012
Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomasXue-Cheng Bi, Jiu-Min Liu, Hui-Chang He, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Molecular Biology Reports|January 24, 2014
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerXiao-hui Ling, Zhao-dong Han, Dan Xia, et al.
Nature Neuroscience|February 24, 2018
Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletionYubin Huang, Zhen Xu, Shanshan Xiong, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancerChao Cai, Jin-Yan Chen, Zhao-Dong Han, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancerYa-Qiang Huang, Zhao-Dong Han, Yu-Xiang Liang, et al.
Pageof 7